Witte EA - Search Results

1

Influence of age, gender, health status, and depression on quantitative EEG.

Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. Morgan ML, et al. Among authors: witte ea. Neuropsychobiology. 2005;52(2):71-6. doi: 10.1159/000086608. Epub 2005 Jun 29. Neuropsychobiology. 2005. PMID: 15990459

2

Neurophysiologic predictors of treatment response to fluoxetine in major depression.

Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ. Cook IA, et al. Psychiatry Res. 1999 Mar 22;85(3):263-73. doi: 10.1016/s0165-1781(99)00010-4. Psychiatry Res. 1999. PMID: 10333379 Clinical Trial.

3

Early changes in prefrontal activity characterize clinical responders to antidepressants.

Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Cook IA, et al. Neuropsychopharmacology. 2002 Jul;27(1):120-31. doi: 10.1016/S0893-133X(02)00294-4. Neuropsychopharmacology. 2002. PMID: 12062912 Clinical Trial.

4

Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.

Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. Cook IA, et al. Int J Geriatr Psychiatry. 2002 Jul;17(7):610-8. doi: 10.1002/gps.644. Int J Geriatr Psychiatry. 2002. PMID: 12112157

5

Longitudinal progression of subclinical structural brain disease in normal aging.

Cook IA, Leuchter AF, Morgan ML, Dunkin JJ, Witte E, David S, Mickes L, O'Hara R, Simon S, Lufkin R, Abrams M, Rosenberg S. Cook IA, et al. Am J Geriatr Psychiatry. 2004 Mar-Apr;12(2):190-200. Am J Geriatr Psychiatry. 2004. PMID: 15010348

6

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.

Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Leuchter AF, et al. Psychopharmacology (Berl). 2004 Dec;177(1-2):15-22. doi: 10.1007/s00213-004-1919-2. Epub 2004 Jul 14. Psychopharmacology (Berl). 2004. PMID: 15252704 Clinical Trial.

7

Changes in brain function of depressed subjects during treatment with placebo.

Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Leuchter AF, et al. Among authors: witte ea. Am J Psychiatry. 2002 Jan;159(1):122-9. doi: 10.1176/appi.ajp.159.1.122. Am J Psychiatry. 2002. PMID: 11772700 Clinical Trial.

8

Corrigendum to 'Neurophysiologic predictors of treatment response to fluoxetine in major depression'.

Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ. Cook IA, et al. Psychiatry Res. 2000 Jul 24;95(1):87. doi: 10.1016/s0165-1781(00)00170-0. Psychiatry Res. 2000. PMID: 10904127 No abstract available.

9

Pemoline produces ipsilateral turning behavior in unilateral 6-OHDA-lesioned rats.

Cromwell HC, Witte EA, Crawford CA, Ly HT, Maidment NT, King BH. Cromwell HC, et al. Among authors: witte ea. Prog Neuropsychopharmacol Biol Psychiatry. 1996 Apr;20(3):503-14. doi: 10.1016/0278-5846(96)00013-9. Prog Neuropsychopharmacol Biol Psychiatry. 1996. PMID: 8771605

10

Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance.

Witte EA, Davidson MC, Marrocco RT. Witte EA, et al. Psychopharmacology (Berl). 1997 Aug;132(4):324-34. doi: 10.1007/s002130050352. Psychopharmacology (Berl). 1997. PMID: 9298509 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters